The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial

BACKGROUND: Irritable bowel syndrome (IBS) is a functional disorder of the digestive tract that causes chronic abdominal symptoms. We evaluated the effects of Lactobacillus brevis KB290 (KB290), which has been demonstrated to be effective at improving bowel movements and the composition of intestina...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Katsumi, Habukawa, Chizu, Nobuta, Yukihiro, Moriguchi, Naohiko, Takemura, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489517/
https://www.ncbi.nlm.nih.gov/pubmed/22863114
http://dx.doi.org/10.1186/1751-0759-6-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489517/
https://www.ncbi.nlm.nih.gov/pubmed/22863114
http://dx.doi.org/10.1186/1751-0759-6-16

Ejemplares similares